510(k) Report

510(k) · Cleared

Cleared

Endoform Restella

K183398510(k) TraditionalCleared Apr 11, 2019125-day reviewClass II21 CFR 878.3300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aroa Biosurgery, Ltd. · FTM Mesh, Surgical

Cleared on Apr 11, 2019 after a 125-day review. The FDA summary names no predicate by number. 3 later devices descend from it.

Decided
Apr 11, 2019
Review
125 days
Class
Class II
Product code
FTM
Recalls
None
Predicates
0

3 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2023: 1 descendant cleared2024: 2 descendants cleared201620182020202220242026
  1. This deviceK183398 Endoform RestellaAroa Biosurgery, Ltd. · 2019
  2. Descendant · cites it directly · 1 of its ownK214070 OviTex PRS (Long Term Resorbable)Tela Bio · 2023
  3. Descendant · 2 generations on · 0 of its ownK243595 OviTex PRS (Long-Term Resorbable)TELA Bio, Inc. · 2024
  4. Descendant · cites it directly · 0 of its ownK241126 OviTex PRSTELA Bio, Inc. · 2024

Most influential descendants

Showing 3 of 3 · See all
  • K214070OviTex PRS (Long Term Resorbable)Tela Bio · 2023 · cites it directly1descendant
  • K243595OviTex PRS (Long-Term Resorbable)TELA Bio, Inc. · 2024 · 2 generations on0descendants
  • K241126OviTex PRSTELA Bio, Inc. · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K183398Endoform RestellaAroa Biosurgery, Ltd.2019—
+1K214070OviTex PRS (Long Term Resorbable)Tela Bio2023—
+2K243595OviTex PRS (Long-Term Resorbable)TELA Bio, Inc.2024—
+1K241126OviTex PRSTELA Bio, Inc.2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
202420
FIG. 1 — Lineage of K183398, 2019–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FTM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FTM device

  1. #1 K262406 EluPro Antibiotic-Eluting BioEnvelopescore 15.1 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K214070OviTex PRS (Long Term Resorbable)Tela Bio20231
K241126OviTex PRSTELA Bio, Inc.20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K214070 (Tela Bio, 2023) has gone furthest, with 1 descendant of its own.

How does its category compare?

All FTM devices

FTM Mesh, Surgical: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · FTM

1in 2025

2007: 92008: 92009: 72010: 22011: 62012: 42013: 42014: 82015: 42016: 72017: 92018: 22019: 62020: 42021: 42023: 22024: 32025: 12026 (partial year): 1
2007high 9 (2007) · low 0 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FTM

29in 2024

2007: 104 days median2008: 86 days median2009: 86 days median2011: 100 days median2012: 66 days median2013: 123 days median2014: 153 days median2015: 316 days median2016: 88 days median2017: 147 days median2019: 107 days median2020: 59 days median2021: 61 days median2024: 29 days median
2007high 316 (2015) · low 29 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FTM

1in 2023

2007: 72008: 12010: 12011: 82018: 212019: 42020: 12021: 12023: 1
2007high 21 (2018) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FTM

232in 2025

2007: 602008: 1412009: 4762010: 1972011: 2882012: 4672013: 3,3512014: 1,0932015: 9772016: 5092017: 5292018: 3572019: 4182020: 4572021: 3692022: 3752023: 4852024: 3832025: 232
2007high 3,351 (2013) · low 60 (2007)2025

MAUDE reports naming product code FTM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079104760
20089861141
20097860476
20102—1197
201161008288
20124660467
2013412303,351
2014815301,093
201543160977
20167880509
201791470529
20182—21357
201961074418
20204591457
20214611369
20220—0375
20232—1485
20243290383
20251—0232
20261—0—
Cite this page

510(k) Report. “K183398: Endoform Restella.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K183398

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026